Dr Daniel M Hagan, DPM | |
237 White St Ste 2, Jacksonville, NC 28546-6351 | |
(910) 577-4977 | |
(910) 577-4980 |
Full Name | Dr Daniel M Hagan |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 41 Years |
Location | 237 White St Ste 2, Jacksonville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013913276 | NPI | - | NPPES |
8908068 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 206 (North Carolina) | Secondary |
213ES0103X | Podiatrist - Foot & Ankle Surgery | 206 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Well Care Home Health | Wilmington, NC | Home health agency |
Onslow Memorial Hospital | Jacksonville, NC | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel M Hagan, DPM 1404 Clifton Rd, Jacksonville, NC 28540-8202 Ph: (910) 382-7424 | Dr Daniel M Hagan, DPM 237 White St Ste 2, Jacksonville, NC 28546-6351 Ph: (910) 577-4977 |
News Archive
VTT Technical Research Centre of Finland has developed a lightweight, handheld, ultra-precision hyperspectral camera for the detection of skin cancers and their precursors. From the surface of the skin, the camera recognises early stages of cancer that are invisible to the naked eye. Collaborators in the pilot study are the University of Jyväskylä, the Päijät-Häme Central Hospital and the Skin and Allergy Hospital of Helsinki University Central Hospital.
Pharmaceutical residues from domestic dwellings, hospitals and agriculture are contaminating our water.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, announces the initiation of two further programmes under its existing alliance with GSK covering novel RNA-based treatments for Duchenne Muscular Dystrophy (DMD). The initiation of these additional programs under the terms of the existing alliance agreement is a validation of both the potential of Prosensa's "exon skipping" platform and the ongoing relationship.
Sleep disturbances among Hispanics may increase their risk of cognitive impairment and Alzheimer's disease, according to a new study led by a University of Miami Miller School neurologist and sleep expert.
› Verified 5 days ago